Whitehawk Therapeutics CEO Dave Lennon presented at TD Cowen’s 46th Annual Healthcare Conference, outlining the company’s strategy to develop a portfolio of next-generation antibody-drug conjugates ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果一些您可能无法访问的结果已被隐去。
显示无法访问的结果